Patents by Inventor Tinglan Tina Albershardt

Tinglan Tina Albershardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
    Patent number: 11365230
    Abstract: This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: June 21, 2022
    Assignee: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund, Tinglan Tina Albershardt
  • PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER
    Publication number: 20220054611
    Abstract: The present invention provides novel compositions and methods for inhibiting tumor growth, treating cancer, and/or inducing immune responses. Such compositions and methods induce an immune response for the treatment of a variety of diseases including cancer.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 24, 2022
    Applicant: IMMUNE DESIGN CORP.
    Inventors: Peter Lars Aksel Berglund, Tinglan Tina Albershardt, Jan Henrik Ter Meulen, Jardin Alexandra Leleux
  • COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF
    Publication number: 20190375811
    Abstract: This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.
    Type: Application
    Filed: November 8, 2016
    Publication date: December 12, 2019
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund, Tinglan Tina Albershardt